Abstract
Death due to SARS-CoV-2 generally occurs in patients requiring hospital care (hospitalization). However, it is still unclear whether vaccination acts as a protective factor against hospitalization in SARS-CoV-2 patients in Indonesia. This study examines the association between vaccination and hospitalization among SARS-CoV-2 patients. It employs a quantitative, cross-sectional design using secondary data from SARS-CoV-2 surveillance records at the Jakarta Health Agency (January–August 2021). Findings show that patients who received the 1st vaccine dose had a 0.34 times lower risk of hospitalization compared to unvaccinated individuals (aPOR=0.34; 95% CI=0.31–0.38). Those who received the 2nd dose had an even lower risk (aPOR=0.16; 95% CI=0.14–0.18). Additionally, gender, age, and chronic kidney disease were significantly associated with hospitalization. These results indicate that vaccination reduces hospitalization risk among SARS-CoV-2 patients, even after adjusting for gender, age, and chronic kidney disease. The government should expand vaccination coverage, especially for high-risk groups. Further research is needed to assess vaccine effectiveness based on different vaccine types in preventing hospitalization in Indonesia.
References
1. Becker C, Beck K, Zumbrunn S, Memma V, Herzog N, Bissmann B, et al. Long COVID 1 year after hospitalisation forCOVID-19: a prospective bicentric cohort study. Swiss Medical Weekly. 2021;(October):1–11.
2. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) [Internet]. CDC. 2023 [cited 2023 Feb 1]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covid-net/purpose-methods.html#::text=About COVID-NET-,Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network,care hospitals in 14 states
3. Bergman J, Ballin M, Nordström A, Nordström P. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. European Journal of Epidemiology. 2021;36(3):287–98.
4. Alharbi AHM, Rabbani SI, Halim Mohamed AA, Almushayti BK, Aldhwayan NI, Almohaimeed AT, et al. Analysis of potential risk factors associated with COVID-19 and hospitalization. Frontiers in Public Health. 2022;10.
5. World Health Organization. Coronavirus disease (COVID-19): Vaccines [Internet]. WHO. 2022 [cited 2023 Jan 25]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines
6. Uzun O, Akpolat T, Varol A, Turan S, Bektas SG, Cetinkaya PD, et al. COVID-19: vaccination vs. hospitalization. Infection. 2022;50(3):747–52.
7. Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infectious Diseases of Poverty. 2021;10(1):1–15.
8. Wu N, Joyal-Desmarais K, Ribeiro PAB, Vieira AM, Stojanovic J, Sanuade C, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta- analysis up to December, 2022. Lancet Respiratory Medicine. 2023;11(January):439–52.
9. Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Gavrilov D, Giattino C, et al. Coronavirus Pandemic (COVID-19) [Internet]. Our World in Data. 2020 [cited 2023 Jan 27]. Available from: https://ourworldindata.org/coronavirus
10. Centers for Disease Control and Prevention. COVID Data Tracker Weekly Review [Internet]. CDC. 2022 [cited 2023 Jan 27]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html
11. Kementerian Kesehatan Republik Indonesia. 84% Pasien COVID-19 yang Meninggal Dunia Belum Booster [Internet]. covid19.go.id. 2022 [cited 2023 Jan 27]. Available from: https://covid19.go.id/artikel/2022/11/13/84-pasien-covid-19-yang-meninggal-dunia-belum-booster
12. Tim Komunikasi Komite Penanganan Corona Virus Disease 2019 (Covid-19) dan Pemulihan Ekonomi Nasional. Tujuan Program Vaksinasi Tercapainya Herd Immunity - Vaksin [Internet]. covid19.go.id. 2021 [cited 2023 Jan 25]. Available from: https://covid19.go.id/p/vaksin/tujuan-program-vaksinasi-tercapainya-herd-immunity
13. World Health Organization. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [Internet]. data.who.int. 2023 [cited 2023 Jan 25]. Available from: https://covid19.who.int/
14. World Health Organization. Indonesia: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [Internet]. data.who.int. 2023 [cited 2023 Jan 25]. Available from: https://covid19.who.int/region/searo/country/id
15. Kementrian Kesehatan Republik Indonesia. Vaksin COVID-19 Nasional [Internet]. vaksin.kemkes.go.id. 2022 [cited 2023 Jan 25]. Available from: https://vaksin.kemkes.go.id/#/vaccines
16. Kementrian Kesehatan Republik Indonesia. Vaksinasi COVID-19 Provinsi [Internet]. vaksin.kemkes.go.id2. 2022 [cited 2023 Jan 25]. Available from: https://vaksin.kemkes.go.id/#/provinces
17. Dinas Kesehatan DKI Jakarta. Peta Persebaran Positif COVID-19 di Jakarta [Internet]. 2023 [cited 2023 Jan 25]. Available from: https://corona.jakarta.go.id/id/peta-persebaran
18. Dinas Kesehatan DKI Jakarta. Cakupan Vaksinasi COVID Dosis Keempat di Jakarta Baru 10% Begini Datanya [Internet]. 2023 [cited 2024 Jan 2]. Available from: https://news.detik.com/berita/d-7085872/cakupan-vaksinasi-covid-dosis-keempat-di-jakarta-baru-10-begini-datanya
19. Halloran ME, Longini IM, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiologic Reviews. 1999;21(1):73–88.
20. WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192(January):19–21.
21. Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. New England Journal of Medicine. 2021;384(15):1412–23.
22. Sofa A. Covid-19 [Internet]. 2021 [cited 2024 Jan 2]. Available from: https://corona.jakarta.go.id/en/artikel/inilah-tahapan-vaksinasi-covid-19-di-jakarta
23. Dinas Kesehatan DKI Jakarta. Dinas Kesehatan DKI Jakarta. Surveilans Dinas Kesehatan Provinsi DKI Jakarta [Internet]. 2023. Available from: https://jakarta.go.id/page/surveilans-dinas-kesehatan-provinsi-dki-jakarta
24. World Health Organization. Public Health Surveillance [Internet]. [cited 2024 Jan 2]. Available from: https://www.emro.who.int/health-topics/public-health-surveillance/index.html
25. Dinas Kesehatan Provinsi DKI Jakarta. Profil Kesehatan Provinsi DKI Jakarta 2020. 2020.
26. Tamhane AR, Westfall AO, Burkholder GA, Cutter GR. Prevalence Odds Ratio versus Prevalence Ratio: Choice Comes with Consequences. Stat Med. 2016;35(30):5730–5.
27. Larese Filon F, Rui F, Ronchese F, De Michieli P, Negro C. Incidence of COVID-19 infection in hospital workers from March 1, 2020 to May 31, 2021 routinely tested, before and after vaccination with BNT162B2. Scientific Reports. 2022;12(1):1–9.
28. Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, et al. Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity JAMA. JAMA. 2021;326(20):2043–5.
29. Wirawan GBS, Harjana NPA, Nugrahani NW, Januraga PP. Health Beliefs and Socioeconomic Determinants of COVID-19 Booster Vaccine Acceptance: An Indonesian Cross-Sectional Study. Vaccines. 2022;10(5):1–14.
30. Biswas N, Mustapha T, Khubchandani J, Price JH. The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers. Journal of Community Health. 2021;46(6):1244–51.
31. Stoliaroff-Pepin A, Peine C, Herath T, Lachmann J, Perriat D, Dörre A, et al. Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022. Vaccine. 2023;41(2):290–3.
32. Asai Y, Nomoto H, Hayakawa K, Matsunaga N, Tsuzuki S, Terada M, et al. Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan. Gerontology. 2022;
33. Lee JY, Kim HA, Huh K, Hyun M, Rhee JY, Jang S, et al. Risk factors for mortality and respiratory support in elderly patients hospitalized with COVID-19 in Korea. Journal of Korean Medical Science. 2020;35(23):1–12.
34. Ramos-Rincon JM, Buonaiuto V, Ricci M, Martín-Carmona J, Paredes-Ruíz D, Calderón-Moreno M, et al. Clinical characteristics and risk factors for mortality in very old patients hospitalized with covid-19 in spain. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2021;76(3):E28–37.
35. Nguyen NT, Chinn J, de Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS ONE. 2021;16(7 July):1–6.
36. Long JD, Storhbehn I, Sawtell R, Bhattacharyya R, Sise ME. COVID-19 Survival and its impact on chronic kidney disease. Translational Research. 2022;241(Maret):70–82.
37. Ozturk S, Turgutalp K, Arici M, Odabas AR, Altiparmak MR, Aydin Z, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: A nationwide analysis from Turkey. Nephrology Dialysis Transplantation. 2021;35(12):2083–95.
38. Su K, Ma Y, Wang Y, Song Y, Lv X, Wei Z, et al. How we mitigated and contained the COVID-19 outbreak in a hemodialysis center: Lessons and experience. Infection Control and Hospital Epidemiology. 2020;41(10):1240–2.
Recommended Citation
Simanjorang, Chandrayani; Tarigan, Kristin Mutiara; Sudrajat, Diva Anita Churiana; Wangsawinangun, Rana Zahra Raniyah; and Zahra, Asy Syifa Anwari
(2025)
"Vaccination as a Protective Factor Against Hospitalization for SARS-CoV-2 Infections: an Observational Study Using Surveillance Data,"
Jurnal Biostatistik, Kependudukan, dan Informatika Kesehatan: Vol. 5:
No.
2, Article 4.
DOI: 10.7454/bikfokes.v5i2.1084
Available at:
https://scholarhub.ui.ac.id/bikfokes/vol5/iss2/4
